SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sudarshan Pharma Industries enters into Rent Agreement with Daundi Biological

07 Jan 2025 Evaluate

Sudarshan Pharma Industries has entered into a Rent Agreement with Daundi Biological to acquire premises for a period of 5 years commencing from December 29, 2024 to set up a new Research & Development formulation centre in the city of Dehradun, Uttarakhand, India. It is expected to commence the operations of the formulation R&D Centre in the month of March 2025. 

Sudarshan Pharma Industries is engaged in contract manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.


Sudarshan Pharma (I) Share Price

39.49 1.60 (4.22%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: